353 related articles for article (PubMed ID: 14530367)
1. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
Merz D; Liu R; Johnson K; Terkeltaub R
J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
[TBL] [Abstract][Full Text] [Related]
2. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
[TBL] [Abstract][Full Text] [Related]
3. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.
Cecil DL; Terkeltaub R
J Immunol; 2008 Jun; 180(12):8378-85. PubMed ID: 18523305
[TBL] [Abstract][Full Text] [Related]
4. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes.
Cecil DL; Rose DM; Terkeltaub R; Liu-Bryan R
Arthritis Rheum; 2005 Jan; 52(1):144-54. PubMed ID: 15641067
[TBL] [Abstract][Full Text] [Related]
6. Chondrocyte hypertrophy and apoptosis induced by GROalpha require three-dimensional interaction with the extracellular matrix and a co-receptor role of chondroitin sulfate and are associated with the mitochondrial splicing variant of cathepsin B.
Olivotto E; Vitellozzi R; Fernandez P; Falcieri E; Battistelli M; Burattini S; Facchini A; Flamigni F; Santi S; Facchini A; Borzi' RM
J Cell Physiol; 2007 Feb; 210(2):417-27. PubMed ID: 17096385
[TBL] [Abstract][Full Text] [Related]
7. Growth-related oncogene alpha induction of apoptosis in osteoarthritis chondrocytes.
Borzi RM; Mazzetti I; Magagnoli G; Paoletti S; Uguccioni M; Gatti R; Orlandini G; Cattini L; Facchini A
Arthritis Rheum; 2002 Dec; 46(12):3201-11. PubMed ID: 12483724
[TBL] [Abstract][Full Text] [Related]
8. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts.
Prasadam I; van Gennip S; Friis T; Shi W; Crawford R; Xiao Y
Arthritis Rheum; 2010 May; 62(5):1349-60. PubMed ID: 20155832
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.
Adamczyk M
Amino Acids; 2017 Mar; 49(3):625-633. PubMed ID: 27510997
[TBL] [Abstract][Full Text] [Related]
10. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.
Johnson KA; Rose DM; Terkeltaub RA
J Cell Sci; 2008 Jul; 121(Pt 13):2256-64. PubMed ID: 18544639
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products.
Cecil DL; Johnson K; Rediske J; Lotz M; Schmidt AM; Terkeltaub R
J Immunol; 2005 Dec; 175(12):8296-302. PubMed ID: 16339570
[TBL] [Abstract][Full Text] [Related]
12. Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.
Fuhler GM; Knol GJ; Drayer AL; Vellenga E
J Leukoc Biol; 2005 Feb; 77(2):257-66. PubMed ID: 15561756
[TBL] [Abstract][Full Text] [Related]
13. Cell surface heparan sulfate participates in CXCL1-induced signaling.
Wang D; Sai J; Richmond A
Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
[TBL] [Abstract][Full Text] [Related]
14. Asiatic acid attenuates hypertrophic and fibrotic differentiation of articular chondrocytes via AMPK/PI3K/AKT signaling pathway.
Liu N; Fu D; Yang J; Liu P; Song X; Wang X; Li R; Fu Z; Chen J; Gong X; Chen C; Yang L
Arthritis Res Ther; 2020 May; 22(1):112. PubMed ID: 32398124
[TBL] [Abstract][Full Text] [Related]
15. p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation.
Stanton LA; Sabari S; Sampaio AV; Underhill TM; Beier F
Biochem J; 2004 Feb; 378(Pt 1):53-62. PubMed ID: 14594450
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.
Huebner JL; Johnson KA; Kraus VB; Terkeltaub RA
Osteoarthritis Cartilage; 2009 Aug; 17(8):1056-64. PubMed ID: 19328881
[TBL] [Abstract][Full Text] [Related]
17. GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease?
Xia M; Hyman BT
J Neuroimmunol; 2002 Jan; 122(1-2):55-64. PubMed ID: 11777543
[TBL] [Abstract][Full Text] [Related]
18. Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis.
Pesesse L; Sanchez C; Delcour JP; Bellahcène A; Baudouin C; Msika P; Henrotin Y
Osteoarthritis Cartilage; 2013 Dec; 21(12):1913-23. PubMed ID: 23973427
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway.
Wang D; Richmond A
J Biol Chem; 2001 Feb; 276(5):3650-9. PubMed ID: 11062239
[TBL] [Abstract][Full Text] [Related]
20. Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase.
Thomas B; Thirion S; Humbert L; Tan L; Goldring MB; Béréziat G; Berenbaum F
Biochem J; 2002 Mar; 362(Pt 2):367-73. PubMed ID: 11853544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
